Foscarnet Injection and Panobinostat: Interaction Details

Brand names
Foscarnet Injection
Foscavir
Panobinostat
Farydak
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Foscarnet Injection and Panobinostat interaction:

Share

Share this interaction

Panobinostat

Brand name
  • Farydak

We don't have a drug information page for Panobinostat yet. Have a question about Panobinostat? Ask a pharmacist, free →

What Happens When You Take Foscarnet Injection With Panobinostat

What can happen when they are taken together (rated Major)

Increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Because effects on the may occur, panobinostat should not be given together with drugs that prolong the QT interval. When use alongside antiemetics known to prolong the QT interval cannot be avoided, ECGs should be performed frequently.

If the Fridericia-corrected QT interval reaches 480 msecs or higher, treatment should be interrupted. Panobinostat should be discontinued if the QT-interval prolongation persists once any electrolyte abnormalities have been corrected.1

The Foscarnet Injection and Panobinostat Interaction, Explained

Both foscarnet (Foscavir), an antiviral given by IV, and panobinostat (Farydak), a cancer medicine, can affect the heart's electrical rhythm. Each one can lengthen something called the , which is the time your heart takes to reset between beats. Together, that effect could add up and raise the chance of an abnormal heart rhythm.

This is a theoretical concern based on how the drugs work, but it is taken seriously. Foscarnet can also lower minerals like calcium, magnesium, and potassium, and low levels can make rhythm problems more likely. Please keep taking your medicines as prescribed and talk with your pharmacist or doctor. Your care team can manage this with heart tracings (ECGs) and mineral checks.

() between panobinostat and foscarnet. Foscarnet is also associated with QT prolongation, and its of divalent cations (hypocalcemia, , ) can add to arrhythmic risk. Evidence is theoretical; onset unspecified; severity major.

  • Labeling advises against of panobinostat with QT-prolonging drugs.
  • If use is unavoidable, obtain frequent monitoring and check and correct electrolytes.
  • Interrupt panobinostat if QTcF reaches 480 msec or more.
  • Discontinue panobinostat if QT prolongation persists after electrolyte correction.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Foscarnet Injection and Panobinostat Interact

The likely mechanism


In short: Foscarnet injection and panobinostat both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Foscarnet Injection and Panobinostat Interaction

Because this combination is generally not recommended, your care team will weigh whether both are needed. If they are, here is what they typically do:

  • Check your heart rhythm with ECGs more often than usual.
  • Check and correct your electrolytes (blood minerals).
  • Pause panobinostat if your gets too long (480 msec or more), and stop it if the problem does not resolve after electrolytes are corrected.

Keep taking both medicines as prescribed unless your team tells you otherwise. Tell them right away about fainting, dizziness, a racing or irregular heartbeat, or seizures. Also share any other medicines you take, especially anti-nausea drugs.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Foscarnet Injection or Panobinostat need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Foscarnet Injection and Panobinostat: Common Questions

How serious is the Foscarnet Injection and Panobinostat interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Foscarnet Injection and Panobinostat interaction managed?

Because this combination is generally not recommended, your care team will weigh whether both are needed. If they are, here is what they typically do: Check your heart rhythm with ECGs more often than usual. Check and correct your electrolytes (blood minerals). Pause panobinostat if your gets too long (480 msec or more), and stop it if the problem does not resolve after electrolytes ar… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Foscarnet Injection and Panobinostat Interaction

Ask in your own words about taking Foscarnet Injection and Panobinostat together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: FARYDAK(R) oral capsules, panobinostat oral capsules. Novartis Pharmaceuticals Corporation (per FDA), East Hanover, NJ, 2015. DailyMed
Was this write-up helpful?

Other Serious Interactions of Foscarnet Injection and Panobinostat

Also serious with Foscarnet Injection

Also serious with Panobinostat

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Panobinostat

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.